Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System criteria for predicting extraprostatic extension by using 3-T multiparametric MR imaging

Radiology

Volumn 276, Issue 2, 2015, Pages 479-489

  Bittencourt, Leonardo Kayat ^a,b,c   Litjens, Geert ^a   Hulsbergen van De Kaa, Christina A ^a   Turkbey, Baris ^d   Gasparetto, Emerson Leandro ^b,c   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Radiology ^*  (Brazil)

^c CDPI Clinica de Diagnostico por Imagem Centro Medico Barra Shopping   (Brazil)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; AGED; CLASSIFICATION; EUROPE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANIZATION; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES; PROGNOSIS; PROSTATE TUMOR; RADIOLOGY; STANDARDS; TUMOR INVASION; UROLOGY;

AGED; EUROPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOLOGY; RETROSPECTIVE STUDIES; SOCIETIES; UROLOGY;

EID: 84938685011     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.15141412     Document Type: Article

References (24)

1. Sciarra A, Barentsz J, Bjartell A, et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 2011;59(6):962-977.
2. Eberhardt SC, Carter S, Casalino DD, et al. ACR Appropriateness Criteria prostate cancer - pretreatment detection, staging, and surveillance. J Am Coll Radiol 2013;10(2):83-92.
3. Shao YH, Demissie K, Shih W, et al. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 2009;101(18):1280-1283.
4. Boccon-Gibod L, Bertaccini A, Bono AV, et al. Management of locally advanced prostate cancer: a European consensus. Int J Clin Pract 2003;57(3):187-194.
5. Yamada AH, Lieskovsky G, Petrovich Z, Chen SC, Groshen S, Skinner DG. Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer. Am J Clin Oncol 1994;17(4):277-285.
6. Loeb S, Smith ND, Roehl KA, Catalona WJ. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. Urology 2007;69(6):1170-1175.
7. Bostwick DG. Staging prostate cancer-1997: current methods and limitations. Eur Urol 1997;32(Suppl 3):2-14.
8. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243(1):28-53.
9. Fütterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer: local staging at 3-T endorectal MR imaging - early experience. Radiology 2006;238(1):184-191.
10. Hegde JV, Chen MH, Mulkern RV, Fennessy FM, D'Amico AV, Tempany CM. Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2013;85(2):e101-e107.
11. Brajtbord JS, Lavery HJ, Nabizada-Pace F, Senaratne P, Samadi DB. Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer. BJU Int 2011;107(9):1419-1424.
12. Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012;22(4):746-757.
13. Portalez D, Rollin G, Leandri P, et al. Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol 2010;20(12):2781-2790.
14. Rosenkrantz AB, Kim S, Lim RP, et al. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 2013;269(2):482-492.
15. Schimmöller L, Quentin M, Arsov C, et al. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol 2013;23(11):3185-3190.
16. Roethke MC, Kuru TH, Schultze S, et al. Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusionguided biopsy at 3.0 Tesla. Eur Radiol 2014;24(2):344-352.
17. Vos PC, Hambrock T, Barenstz JO, Huisman HJ. Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRI. Phys Med Biol 2010;55(6):1719-1734.
18. Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011;59(4):477-494.
19. Hambrock T, Somford DM, Huisman HJ, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011;259(2):453-461.
20. Hoeks CM, Hambrock T, Yakar D, et al. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 2013;266(1):207-217.
21. Fütterer JJ, Engelbrecht MR, Huisman HJ, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005;237(2):541-549.
22. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005;29(9):1228-1242.
23. van Veggel BA, van Oort IM, Witjes JA, Kiemeney LA, Hulsbergen-van de Kaa CA. Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy. Histopathology 2011;59(4):692-702.
24. Jager GJ, Severens JL, Thornbury JR, de La Rosette JJ, Ruijs SH, Barentsz JO. Prostate cancer staging: should MR imaging be used? - A decision analytic approach. Radiology 2000;215(2):445-451.